Timothy Coughlin
Director · 6 filings · Latest: Jun 12, 2026
ADC Therapeutics SA
aTYR PHARMA INC
Travere Therapeutics, Inc.
Vir Biotechnology, Inc.
| Ticker | Owner | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total | SEC Filing |
|---|---|---|---|---|---|---|---|---|---|
TVTX | Timothy Coughlin | Director | Jun 12, 2026 | Sale | $50.07 | 10,000 | $500.7K | 56,250 | |
TVTX | Timothy Coughlin | Director | Jun 12, 2026 | Option Exercise | $26.52 | 10,000 | $265.2K | 66,250 | |
TVTX | Coughlin Timothy | — | Jun 12, 2026 | Proposed Sale | $50.04 | 10,000 | $500.4K | — | |
TVTX | Timothy Coughlin | Director | May 15, 2026 | Sale | $43.49 | 3,250 | $141.3K | 52,250 | |
TVTX | Coughlin Timothy | — | May 15, 2026 | Proposed Sale | $43.44 | 3,250 | $141.2K | — | |
TVTX | Coughlin Timothy | — | Oct 31, 2025 | Proposed Sale | $34.98 | 18,000 | $629.7K | — |